Abstract
Mitogenic stimulation is likely to be an important component of tumor promotion. However, that alone is not sufficient for transformation, and changes in gene expression are required to avoid growth regulation or differentiation. In general, alterations in the transcription of a specific set of cellular genes are mediated by specific regulatory DNA binding proteins or transcription factors that regulate gene expression directly by binding to specific DNA sequences in promoter regions (1–9). The expression of genes transcriptionally induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) and other tumor promoters such as UV irradiation are thought to be required in tumor promotion (4–10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Beckman HH, Chen JL, O’Brien T, Tjian R. Coactivator and promoter-selective properties of RNA polymerase I TAFS. Science 1995; 270:1505–1509
O’Brien T, Lis JT. Rapid changes in Drosophila transcription after an instantaneous heat shock. Mol Cell Biol 1993; 13:3456–3463
Matrisian LM, McDonnel S, Miller DB, Navre M, Seftor EA, Hendrix MJC. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991; 302:157–162
Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P. 12–0tetradecanoyl-phorbol-l3-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5’-flanking region. Mol Cell Biol 1987; 7:12–0
Dong Z, Colburn NH. AP-1: a molecular target for prevention of carcinogenesis. In: S Srivastava, SM Lippman, WK Hong, and JL Mulshine (eds.), Early Detection of Cancer, pp. 123–130, Futura Publishing Corp, Armonk, NY, 1994
Angel P. The role and regulation of Jun proteins in response to phorbol ester and UV light. In: PA Baeurle (ed.), Induced Gene Expression, Vol. 1, pp. 62–92, Birkhauser, Boston, 1995
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76:1025–1037
Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-Jun gene during the mammalian UV response. Mol Cell Biol 1991; 11:2804–2811
Devary Y, Rosette C, DiDonato JA, Karin M. NFKB activation by ultraviolet light not dependent on a nuclear signal. Science 1993; 261:1442–1445
Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colbum NH. Blocking tumor promoter induced AP-I activity inhibits transformation in JB6 cells. Proc Natl Acad Sci USA 1994; 91:609–613
Huang C, Ma WY, Dawson MI, Rincon M, Flavell RA, Dong Z. Blocking AP-1 activity, but not activating RARE, is required for anti-tumor promotion effects by retinoic acid. Proc Natl Acad Sci USA 1997; 94:5826–5830
Dong Z, Watts SG, Sun Y, Colburn NH. Progressive elevation of AP-1 activity during preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Int J Oncol 1995; 7:359–364
Bernstein LR, Colburn NH. AP-1/Jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989; 244:566–569
Domann FE, Levy JP, Birrer MJ, Bowden GT. Stable expression of c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks cellular AP-1 activity and tumor formation in nude mice. Cell Growth & Diff 1994; 5:9–16
Bowden GT, Schneider B, Domann R, Kuleszmartin M. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res 1994; 54:S1882–S1885
Dong Z, Lavrovsky V, Colburn NH. Induction of reversion transformation in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 1995; 16:749–759
Lavrovsky V, Dong Z, Ma W, Colbum NH. Drug induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells. In Vitro Cell & Develop Biol 1996; 32:234–237
Huang C, Schmid PC, Ma WY, Schmid HHO, Dong Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced transformation of AP-1 activation. J Biol Chem 1997; 272:4187–4194
Sun Y, Nakamura K, Hegamyer G, Dong Z, Colburn N. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol Carcinogenesis 1993; 8:49–57
Colburn NH, Wandel E, and Srinivas L. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies. J Cell Biochem 1982; 18:261–270
Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumor promoter induces anchorage independence irreversibly. Nature(London) 1979; 281:589–591
Li JJ, Westergaard C, Ghosh P, Colburn NH. Inhibitors of both nuclear factorkappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 1997; 57:3569–3576
Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991; 65:663–675
Kyriakis JM, Banerjee P, Niolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature(London) 1994; 369:156–160
Davis RJ. MAP kinases: a new JNK expands the group. Trends Biochem Sci 1994; 19:470–473
Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis RJ, Karin M. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994; 8:2996–3007
Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 1988; 55:875–885
Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J ,Kyriakis JM, Zon LI. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994; 372:794–798
Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PCl2 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77:841–852
Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 194; 266:1719–1723
Angel P. The role and regulation of the Jun proteins in response to phorbol ester and UV light. In: PA Baeuerle (ed.), Inducible Gene Expression, pp. 62–92, Birkhauser, Boston, 1995
Boyle WJ, Smeal T, Defize LHK, Angel P, Woodgett JR, Karin M, Hunter T. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 1991; 64:573–584
Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, Karin M. Oncoprotein mediated signaling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 1992; 12:3507–3513
Devary Y, Gottleib RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992; 71:1081–1091
Radler-Pohl A, Sachsenmaier C, Gebel S, Auer HP, Bruder JT, Rapp U, Angel P, Rahmsdorf HJ, Herrlich P. UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J 1993; 12:1005–1012
Huang C, Ma WY, Young C, Colburn NH, Dong Z. The shortage of mitogenactivated protein (MAP) kinase is responsible for the tumor promotion resistant (P-) phenotype of JB6 cells. Proc Natl Acad Sci USA 1998; 95:156–161
Watts RG, Young MR, Huang C, Li JJ, Dong Z, Pennie WD, Colburn NH. Erk is required AP-1 mediated transcriptional activity and neoplastic transformation. Oncogene 1998; in press
Huang C, Ma WY, Li J, Goranson A, Dong Z. Requirement of Erks, but not JNKs, for arsenite-induced cell transformation. l Biol Chem 1999; 274:14595–14601
Huang C, Li J, Ma WY, Dong Z. JNKs activation is required for JB6 cell transformation induced by TNFa but not by TPA. J Biol Chem 1999; in press
Yang CS, Wang ZY. Tea and cancer: a review. J Natl Cancer Inst 1993; 58:1038–1049
Yang CS, Yang GY, Lee ML, Chen L. Mechanistic considerations of the inhibition of carcinogenesis by tea. In: H Ohigashi (ed.), Proceedings of the International Conference on Food Factor in Cancer Prevention, pp. 113–117, Springer-Verlag, Tokyo, 1997
Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncology 1996; 8:221–238
Dreosti IE, Wargovich MJ, Yang CS. Inhibition of carcinogenesis by tea: The evidence from experimental studies. Crit Rev Food Sci & Nutr 1997; 37:761–770
Yoshizawa S, Horiuchi T, Fukiji H, Yoshida T, Okuda T, Sugimura T. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of “tannin” in green tea. Photother Res 1987; 1:44–47
Wang ZY, Khan WA, Bickers DR. Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis (Lond.) 1989; 10:411–415
Gensler HL, Timmermann BN, Valcic S, Wachter GA, Dorr R, Dvorakova K, Alberts DS. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr Cancer 1996; 26:325–335
Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H, Yang CS, Conney AH. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis (Lond.) 1992; 13:947–954
Wang ZY, Huang MT, Ferraro T, Wong CQ, Lou YR, Reuhl K, Latropoulos M, Yang CS, Conney AH. Inhibitory effect of green tea in drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res 1992; 52:1162–1170
Katiyar S, Agarwal R, Wood GS. Inhibition of 12-O-tetradecanoyl-phorbol-l3acetate-caused tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res 1992; 52:6890–6897
Katiyar SK, Agarwal R, Mukhtar H. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR
mice by a polyphenolic fraction isolated from green tea. Cancer Res 1993; 53:5409–5412
Wang ZY, Huang MT, Lou YR, Xie JG, Reuhl KR, Newmark HL, Ho CT, Yang CS, Conney AH. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res 1994; 54:3428–3435
Balentine DA. Manufacturing and chemistry of tea. In: CT Ho, MT Huang, CY Lee (eds.), Phenolic Compounds in Food and their Effects on Health I: Analysis, Occurrence, and Chemistry, pp. 102–117, American Chemical Society, Washington, DC, 1992
Wang ZY, Wang LD, Lee MJ, Ho CT, Huang MT, Conney AH, Yang CS. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis (Lond.) 1995; 16:2143–2148
Huang MT, Xie JG, Wange ZY, Ho CT, Lou YR, Wang CX, Hard GC, Conney AH. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res 1997; 57:2623–2629
Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prey Med 1992; 21:334–350
Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang ZY, Yang CS. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 1993; 68:231–236
Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, in press
Shiraki M, Hara Y, Osawa T, Kumon H, Nakayama T, Kawakishi S. Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat Res 1994; 323:29–34
Yu R, Jiao JJ, Duh JL, Gudehithlu K, Tan th, Kong AN. Activation of itogenactivated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 1997; 18:451–456
Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387:561
Yang CS. Inhibition of carcinogenesis by tea. Nature 1997; 389:134–135
Dong Z, Ma WY, Huang C, Yang CS. Inhibition of tumor promoter-induced AP-1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Cancer Res 1997; 57:4414–4419
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dong, Z., Nomura, M., Huang, C., Ma, Wy. (2001). Effects of Tea Polyphenols on the Signal Transduction Pathways. In: Nutrition and Cancer Prevention. Advances in Experimental Medicine and Biology, vol 492. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1283-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1283-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5477-2
Online ISBN: 978-1-4615-1283-7
eBook Packages: Springer Book Archive